Search clinical trials for: high bleeding riskduration of dual anti-platelet therapy

Total 438470 results

Marco Valgimigli

Unknown

Zotarolimus-eluting Endeavor Sprint Stent in Uncertain DES Candidates (ZEUS) Study (ZEUS)

Coronary Artery Disease

Italy, Switzerland, Portugal, Hungary
Woo-Keun Seo

Not yet recruiting

Highest Efficacy of Dual Antiplatelet Therapy After Carotid Artery Stenting in High Bleeding Risk Patients

Carotid Artery Diseases
Shanghai MicroPort Medical (Group) Co., Ltd.

Recruiting

Comparison One vs Six Months of Dual Antiplatelet Therapy After Implanted Firehawk TM Stent in High Bleeding Risk Patients With Coronary Artery Disease

Coronary Disease | Percutaneous Coronary Intervention | Dual Antiplatelet Therapy | Drug Eluting Stent

China
Yonsei University

Active, not recruiting

A Randomized Comparison of CLOpidogrel Monotherapy Versus Extended Dual-antiplatelet Therapy Beyond 12 Months After Implantation of Drug-eluting StEnts in High-risk Lesions or Patients; A-CLOSE Trial

Coronary Artery Disease | DES

Korea, Republic of
Biotronik AG

Active, not recruiting

Bioflow-DAPT Study

Coronary Artery Disease

Hong Kong, Thailand, France, Latvia, Belgium, Singapore, Switzerland, Spain, New Zealand, Austria, Australia, Malaysia, Denmark, Italy, Germany, Netherlands, Hungary, Poland
Abbott Medical Devices

Completed

XIENCE 28 USA Study

Coronary Artery Disease | Renal Insufficiency | Ischemic Stroke | Anemia | Thrombocytopenia | Coagulation Disorder | Hemorrhagic Stroke | Bleeding Disorder | Hematological Diseases

United States, Hong Kong, Canada, China, Spain, Belgium, Germany, Portugal, Switzerland, Taiwan, United Kingdom, Austria, Italy, Netherlands, Singapore
Instituto Nacional de Cardiologia Ignacio Chavez

Terminated

Drug-eluting Balloon Versus Drug-eluting Stent for High Bleeding Risk Angioplasty (DEBORA)

Coronary Artery Disease (CAD) | Percutaneous Coronary Intervention (PCI) | High Bleeding Risk

Mexico
ECRI bv
University of Bern; European Cardiovascular Research Center; Terumo Medical Corporation and other collaborators

Completed

Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Prolonged DAPT Regimen (MASTER DAPT)

Coronary Artery Disease | PCI | High Bleeding Risk

Netherlands, France, United Kingdom, Australia, Singapore, Japan, Italy, Poland, Spain, Switzerland, Israel, Argentina, Austria, Bahrain, Bangladesh, Belgium, Bulgaria, Czechia, Denmark, Estonia, Germany, Hungary, India, Korea, Republic... and more
Abbott Medical Devices

Completed

XIENCE 28 Global Study

Coronary Artery Disease | Renal Insufficiency | Anemia | Thrombocytopenia | Coagulation Disorder | Stroke, Ischemic | Stroke Hemorrhagic | Bleeding Disorder | Hematological Disease

China, Spain, Belgium, Germany, Portugal, Switzerland, Hong Kong, United Kingdom, Austria, Italy, Netherlands, Singapore, Taiwan
Medtronic Vascular

Completed

A Randomized Controlled Trial With Resolute Onyx in One Month Dual Antiplatelet Therapy (DAPT) for High-Bleeding Risk Patients (Onyx ONE)

Coronary Artery Disease

Korea, Republic of, Spain, Australia, Hong Kong, United Kingdom, Singapore, Thailand, Belgium, New Zealand, Sweden, France, Switzerland, Netherlands, Italy, Slovakia, Lithuania, Austria, Malaysia, Bulgaria, Ireland, Latvia, Norway, ...
Umeå University
Medtronic

Completed

Preoperative Dual Antiplatelet Therapy: Platelet Function and Influence of Cardiopulmonary Bypass

Cardiopulmonary Bypass | Bleeding Disorder | Platelet Dysfunction Due to Drugs | Platelet Disorder

Sweden
Baim Institute for Clinical Research
Bristol-Myers Squibb; Eli Lilly and Company; Daiichi Sankyo, Inc.; Boston Scientific... and other collaborators

Completed

The Dual Antiplatelet Therapy Study (DAPT Study)

Coronary Artery Disease

United States, Australia, Czechia, New Zealand, United Kingdom, Germany, Hungary, Poland, France, Romania
Seoul St. Mary's Hospital
AstraZeneca; The Catholic University of Korea; Chonnam National University

Unknown

CardiOvascular Risk and idEntificAtion of Potential High-risk Population in Acute Myocardial Infarction II (COREA-AMI II)

Bleeding | Percutaneous Coronary Intervention | Acute Myocardial Infarction | Major Adverse Cardiovascular Events

Korea, Republic of
Ain Shams University

Recruiting

HFNC Versus Conventional Oxygen Therapy in Prolonged Upper Gastrointestinal Endoscopy in the ICU

Upper Gastrointestinal Bleeding

Egypt
Xijing Hospital of Digestive Diseases

Recruiting

Standard or Short-course Vonoprazan Non-bismuth Triple Therapy or High-dose Dual Therapy Versus Rabeprazole-bismuth Quadruple Therapy for Primary Helicobacter Pylori Eradication

the Eradication Rates of Helicobacter Pylori

China
University of Kansas Medical Center
National Cancer Institute (NCI)

Not yet recruiting

Relugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate Cancer

Stage IV Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8

United States
Fu Wai Hospital, Beijing, China

Not yet recruiting

Ticagrelor Single Antiplatelet Therapy in Patients With High Risk of Bleeding After DCB for Coronary Small Vessel Disease

Coronary Heart Disease

China
The Affiliated Nanjing Drum Tower Hospital of Nanjing...
Beijing Friendship Hospital; Nanfang Hospital, Southern Medical University

Recruiting

Standard Therapy and TIPS for Moderate to High-risk Esophageal and Gastric Variceal Bleeding

Portal Hypertension

China
iVascular S.L.U.

Not yet recruiting

Ischemic and Bleeding Outcomes After Angiolite Stent Implantation and an Abbreviated Dual Antiplatelet Therapy (ANGIODAPT)

Coronary Artery Disease
Azienda Ospedaliera Universitaria Policlinico "G...
Gianluca Di Bella; Antonio Micari; Giampiero Vizzari; Giorgio Quadri; Greca Zanda; Ferdinando...

Recruiting

De-escalating Antiplatelet Therapy to Assess Platelet Reactivity and Outcomes in High Bleeding Risk Patients With Recent ACS (DESC-HBR)

Coronary Artery Disease | Acute Coronary Syndrome | Dual Antiplatelet Therapy

Italy
Xijing Hospital of Digestive Diseases

Recruiting

Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology

Gastritis | Dyspepsia | Gastric Cancer | Peptic Ulcer | Helicobacter Pylori Infection

China
University of Florida

Recruiting

Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI (TAILOR BLEED)

Coronary Artery Disease

United States
Institute of Cardiology, Warsaw, Poland
Medical Research Agency, Poland

Recruiting

Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure in Dialyzed Patients (SAFE LAAC CKD)

Atrial Fibrillation

Poland
McMaster University
International Society on Thrombosis and Haemostasis

Recruiting

Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS

Antiphospholipid Syndrome | Arterial Thrombosis

Argentina, Canada
Seoul National University Hospital
Hanyang University

Recruiting

HOST - DAPT Duration According the Bleeding Risk (HOST-BR)

Coronary Artery Disease | Stable Angina | Acute Myocardial Infarction

Korea, Republic of
Assistance Publique - Hôpitaux de Paris
Fonds de Dotation ACTION

Not yet recruiting

Assessment of an Early De-Escalation to a Low-potency Single Antiplatelet Therapy Guided by Genetics Versus a Systematic High-Potency Single Antiplatelet Therapy to Neutralize Bleeding Complications in Patients With High Bleeding Risk Beyond One Month After an Acute Coronary Syndrome (ADEN)

MYOCARDIAL INFARCTION

France
Liaocheng People's Hospital

Recruiting

Susceptibility-Guided Sequential Therapy for Helicobacter Pylori Infection

Helicobacter Pylori Infection

China
Shandong University

Not yet recruiting

14-day Double Therapy Versus Bismuth Quadruple Therapy in First-line Treatment of Helicobacter Pylori Infection

Helicobacter Pylori Infection

China
China National Center for Cardiovascular Diseases

Recruiting

Ticagrelor-based De-escalation of Dual Antiplatelet Therapy After Coronary Artery Bypass Grafting (TOP-CABG)

Myocardial Infarction | Myocardial Ischemia | Coronary Artery Disease | Bleeding | Angina Pectoris | Dual Antiplatelet Therapy | Coronary Artery Bypass Grafting

China
National Yang Ming University

Not yet recruiting

Deep Brain Stimulation on Dual-task Gait Performance in PD

Parkinson Disease

Taiwan
Rikke Sorensen

Recruiting

Reduced Antithrombotic Strategy for High Bleeding Risk Patients With Myocardial Infarction (Dan-DAPT)

Myocardial Infarction

Denmark
Kaohsiung Medical University

Recruiting

14-day PCAB-based High-dose Dual Therapy and14-day PCAB-based Triple Therapy vs 14-day PPI-based Reverse Hybrid Therapy

Helicobacter Pylori Eradication

Taiwan
2seventy bio

Recruiting

A Study of bbT369 in Relapsed and/or Refractory B Cell Non-Hodgkin's Lymphoma (NHL)

Diffuse Large B Cell Lymphoma (DLBCL)

United States
Hospital da Senhora da Oliveira

Recruiting

Comparison Between High-dose Amoxicillin Dual Therapy and Pylera Quadruple Therapy in the Treatment of Helicobacter Pylori Infection

Gastritis | Gastric Cancer | Helicobacter Pylori Infection

Portugal
Yonsei University

Not yet recruiting

24-month Ticagrelor-based Dual-antiplatelet Therapy Versus Clopidogrel-based Dual-antiplatelet theRapy aftEr 12 Months of DrUg-eluting Stent Implantation in High isChEmic Risk Patients: P-REDUCE Trial

High Ischemic Risk

Korea, Republic of
Octapharma

Recruiting

Study of OCTAPLEX in Patients With Acute Major Bleeding on DOAC Therapy With Factor Xa Inhibitor

Acute Major Bleeding

United States, Spain, Bosnia and Herzegovina, Croatia, Georgia, Italy, Poland, Germany, Turkey, United Kingdom, Ukraine, France, Austria
The First Affiliated Hospital with Nanjing Medical...

Recruiting

Sintilimab, Anlotinib Hydrochloride and Platinum-Containing Dual-Agent Chemotherapy in NSCLC

Metastatic NSCLC | Recurrent NSCLC | Advanced Non-Small Cell Squamous Lung Cancer

China
Qilu Hospital of Shandong University

Not yet recruiting

The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients

Acute Coronary Syndrome | Helicobacter Pylori Infection

China
National Taiwan University Hospital

Recruiting

Comparison of Vonoprazan-based Versus Lansoprazole-based Triple Therapy, High Dose Dual Therapy, Bismuth and Non-bismuth Quadruple Therapy in the First-line Treatment of Helicobacter Pylori Infection

H. Pylori Infection

Taiwan
Duk-Woo Park, MD

Recruiting

Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy (PROTECT-HBR)

Myocardial Infarction | Coronary Artery Disease | Acute Coronary Syndrome | Percutaneous Coronary Intervention

Korea, Republic of
National Taiwan University Hospital
Ministry of Science and Technology, Taiwan

Recruiting

Efficacies of HDDT With or Without Bismuth vs Amoxicillin-metronidazole BQT for First-line H Pylori Eradication

Helicobacter Pylori Infection

Taiwan
National Institute of Cardiology, Warsaw, Poland
Medical Research Agency, Poland

Recruiting

Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure (SAFE-LAAC)

Atrial Fibrillation

Poland
The Third Xiangya Hospital of Central South University
The Second People's Hospital of Huaihua; Yueyang Hospital of Traditional Chinese...

Completed

Esomeprazole/Vonoprazan Combined With High-dose Amoxicillin Dual Therapy for Primary Eradication of Helicobacter Pylori Infection

Helicobacter Pylori Infection

China
AO GENERIUM

Enrolling by invitation

Study of the Safety and Immunogenicity of Long-term GNR-069 Therapy in ITP Patients

Idiopathic Thrombocytopenic Purpura

Russian Federation
St. Jude Children's Research Hospital
Cookies for Kids' Cancer; CURE Childhood Cancer, Inc.

Active, not recruiting

Therapy for Children With Advanced Stage Neuroblastoma

Neuroblastoma

United States
Duk-Woo Park, MD
CardioVascular Research Foundation, Korea

Active, not recruiting

TAILored Versus COnventional AntithRombotic StratEgy IntenDed for Complex HIgh-Risk PCI (TAILORED-CHIP)

Coronary Stenoses

Korea, Republic of
Shanghai Jiao Tong University School of Medicine

Completed

High-dose Dual Therapy With Different Administration Frequencies

Helicobacter Pylori Infection

China
Abbott Medical Devices
Bristol-Myers Squibb; Eli Lilly and Company; Daiichi Sankyo, Inc.; Baim Institute...

Completed

XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort (XVU-AV DAPT)

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Chronic Total Occlusion of Coronary Artery | Coronary Restenosis | Vascular Disease | Coronary Artery Stenosis

United States
Sixth Affiliated Hospital, Sun Yat-sen University

Completed

Optimization of Vonoprazan--amoxicillin Dual Therapy for Eradicating Helicobacter Pyloriinfection

Helicobacter Pylori Eradication Rate

China
Kaohsiung Veterans General Hospital.

Completed

Comparing the Efficacy of Hybrid, High-dose Dual and Bismuth Quadruple Therapies

Helicobacter Pylori Infection

Taiwan

Search clinical trials for: high bleeding riskduration of dual anti-platelet therapy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Djibouti

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations